Small molecule inhibitors of histone deacetylase

Author：  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.6, 2002-06, pp. : 943-947

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 – 2013)

By Valente Sergio   Mai Antonello  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 401-415

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention

By  

Current Drug Targets, Vol. 19, Iss. 6, 2018-04 ,pp. : 593-601

Bentham Science Publishers

Access to resources Recommend Favorite

From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents

By  

Current Pharmaceutical Design, Vol. 14, Iss. 6, 2008-02 ,pp. : 545-561

Bentham Science Publishers

Access to resources Recommend Favorite

Histone deacetylase inhibitors

By Price Steve   Dyke Hazel J  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 7, 2007-07 ,pp. : 745-765

Informa Healthcare

Access to resources Recommend Favorite

Macrocyclic Histone Deacetylase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1423-1440

Bentham Science Publishers

Access to resources Recommend Favorite